TAK · Takeda Pharmaceutical Co Ltd · Analyst Estimates
$20.93
-0.26 (-1.23%)
At close · Nov 6
Return incl. dividend (before tax)
Play latest call
Q2 2027 earnings call transcript
Market Cap
$67.73B
Shares
3.19B
Volume · Nov 6
219.14K
Avg daily vol (3M)
2.68M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Analyst Estimates
Compare analyst forecasts for Takeda Pharmaceutical Co Ltd across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-11-06 14:21 UTC · Publication dates shown per estimate · 6 metric / period groups
FY ending 2027-03-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
JPY
Publication date not stated |
51.16
|
148.67
|
246.19
|
2
|
154.95
|
149.99
|
51.16
|
147.10
|
0
|
0
|
1
|
0
|
|
Revenue
JPY
Publication date not stated |
4.62T
|
4.71T
|
4.84T
|
16
|
— | — | — | — | — | — | — | — |
FY ending 2028-03-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
JPY
Publication date not stated |
138.53
|
198.63
|
258.73
|
2
|
138.53
|
138.53
|
194.25
|
179.65
|
0
|
0
|
1
|
1
|
|
Revenue
JPY
Publication date not stated |
4.58T
|
4.81T
|
5.12T
|
15
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
JPY
Publication date not stated |
1.23T
|
1.24T
|
1.25T
|
5
|
— | — | — | — | — | — | — | — |
Q ending 2027-03-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
JPY
Publication date not stated |
1.02T
|
1.14T
|
1.23T
|
5
|
— | — | — | — | — | — | — | — |
Key facts
CIK
1395064
CUSIP
874060205
13F (30d)
226 filings
181 filers
Visit website
Investor relations